JACC Specialty Journals

JACC: Advances - Nontraditional Risk Markers for Incident Coronary Artery Calcium Among Persons ≥65 Years of Age 28.02.2024 3:12 ↓

Commentary by Dr. Candice Silversides

JACC: Advances - Sex-Based Differences in Patients With Left Ventricular-Assisted Devices and Strokes 28.02.2024 2:43 ↓

Commentary by Dr. Candice Silversides

JACC: Advances - Renal Biomarkers in Heart Failure: Systematic Review and Meta-Analysis 28.02.2024 2:44 ↓

Commentary by Dr. Candice Silversides

JACC: Advances - Cardiovascular and Non-Cardiovascular Prescribing and Mortality After Takotsubo: Comparison With Myocardial Infarction and General Population 28.02.2024 2:36 ↓

Commentary by Dr. Candice Silversides

JACC: Advances - Underrepresentation of Diverse Ancestries Drives Uncertainty in Genetic Variants Found in Cardiomyopathy-Associated Genes 28.02.2024 3:04 ↓

Commentary by Dr. Candice Silversides

JACC: Clinical Electrophysiology - Impact of Atrial Fibrillation Burden on Healthcare Costs and Utilization 28.02.2024 6:34 ↓

Commentary by Dr. Ratika Parkash

JACC: CardioOncology Pulse - Radiation Therapy for Lung Cancer and Risk of Cardiovascular Disease 27.02.2024 39:21 ↓

Katelyn Atkins, MD, PhD discusses cardiovascular diseases associated with radiation therapy and risk mitigation approaches. Moderated by Sarah Waliany, MD, MS.

JACC: CardioOncology Pulse - Top Takeaways on 'Decoding Immunotherapy: Applying Diagnostic Criteria and Navigating the Complexities of Management' at ACC Advancing the Cardiovascular Care of the Cancer Patient 27.02.2024 17:07 ↓

Nicolas Palaskas, MD, and Susan Dent, MD, provide a review of the latest developments in the diagnosis and management of diverse immune checkpoint-related adverse cardiovascular events, including myocarditis.

JACC: CardioOncology Pulse - Top Takeaways on 'Harmony in Hematology: Cardiovascular Risk Mitigation and Monitoring in Chronic Lymphocytic Leukemia' at ACC Advancing the Cardiovascular Care of the Cancer Patient 27.02.2024 14:14 ↓

Daniel Addison, MD, and Danielle Shafer, DO, discuss the latest updates in the prevention and treatment of cardiovascular disease in patients with chronic lymphocytic leukemia.

JACC: Cardiovascular Interventions - Presence and Relevance of Myocardial Bridge in LAD-PCI of CTO and Non-CTO Lesions 26.02.2024 7:34 ↓

Commentary by Dr. Megha Prasad and Dr. Akiko Maehara

JACC: Cardiovascular Interventions - National Variation in Hospital MTEER Outcomes and Correlation With TAVR Outcomes: STS/ACC TVT Registry Analysis 26.02.2024 8:49 ↓

Commentary by Dr. Abdullah Al-Abcha and Dr. Dharam J. Kumbhani

JACC: Asia Pulse - Metabolic Syndrome in Asia: Public Health Difficulties/Implications for Cardiovascular Health 20.02.2024 26:56 ↓

Neeja Patel MD, and Unjali Gujral, MPH,PhD discuss the epidemiology of metabolic syndrome relating to cardiovascular disease, differences within various ethnic groups, the effect of acculturation, and approaches to address large population health in the future.

JACC: CardioOncology - Heart Failure Readmission in Patients with ST Elevation Myocardial Infarction and Active Cancer 20.02.2024 4:40 ↓

Commentary by Dr. Bobby Yeh and Dr. Aarti Asnani

JACC: CardioOncology - Comparing Anticoagulation Strategies for Venous Thromboembolism Associated with Active Cancer: A Systematic Review and Meta-Analysis 20.02.2024 2:45 ↓

Commentary by Dr. Tzu-Fei Wang

JACC: CardioOncology - Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria in Incidence of Cancer Therapy-Related Cardiac Dysfunction 20.02.2024 4:41 ↓

Commentary by Dr. Laura De Michieli

JACC: CardioOncology - Clinical Outcomes Among Immunotherapy-Treated Patients with Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective Study 20.02.2024 3:37 ↓

Commentary by Dr. Vivek Narayan

JACC: CardioOncology - Heart Failure Post Myocardial Infarction Promotes Mammary Tumor Growth Through the NGF-TRKA Pathway 20.02.2024 3:29 ↓

Commentary by Dr. Richard Von Itter

JACC: CardioOncology - Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related Genes 20.02.2024 4:05 ↓

Commentary by Dr. Nazish Sayed

JACC: CardioOncology - February 2024 Issue Summary 20.02.2024 24:35 ↓

Audio Summary of the February Issue with Introduction by Dr. Bonnie Ky.

JACC: Advances - The Science of Precision Prevention: Research Opportunities and Clinical Applications to Reduce Cardiovascular Health Disparities 13.02.2024 16:43 ↓

Commentary by Dr. Candice Silversides, Dr. Thomas Pearson, and Dr. Charlotte Pratt

JACC: Cardiovascular Interventions - First Experience With Amulet in the United States: Early Insights From EMERGE LAA Post-Approval Study 12.02.2024 10:31 ↓

Commentary by Dr. Mirza Umair Khalid and Dr. Christopher R. Ellis

JACC: Cardiovascular Interventions - Non-Vitamin K Antagonist Versus Vitamin K Antagonist Oral Anticoagulants After Transcatheter Aortic Valve Implantation 12.02.2024 7:43 ↓

Commentary by Dr. Mirza Umair Khalid and Dr. Bashir Alaour

JACC: Asia - Efficacy and Safety of Inclisiran in Asian Patients: Results From ORION-18 06.02.2024 3:47 ↓

Commentary by Dr Aniruddh Patel

JACC: Asia - Aromatase Inhibitor Therapy Increases the Risk of New-Onset Atrial Fibrillation in Patients With Breast Cancer 06.02.2024 2:16 ↓

Commentary by Dr Hidehira Fukaya

JACC: Asia - Neuroticism and the Risk of Atrial Fibrillation: An Observational Epidemiologic and Mendelian Randomization Study 06.02.2024 4:02 ↓

Commentary by Dr Shin Huei Liu